PVLA
Palvella Therapeutics
PVLA
PVLA
98 hedge funds and large institutions have $96.9M invested in Palvella Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 31
25% less capital invested
Capital invested by funds: $129M → $96.9M (-$31.9M)
Holders
98
Holding in Top 10
1
Calls
$693K
Puts
$305K
Top Buyers
| 1 | +$5.14M | |
| 2 | +$4.76M | |
| 3 | +$3.09M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$2.25M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.04M |
Top Sellers
| 1 | -$6.95M | |
| 2 | -$4.01M | |
| 3 | -$3.1M | |
| 4 |
FI
Fosun International
Hong Kong,
China
|
-$1.62M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.61M |